SPONSOR
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Autoinflammatory DiseaseJuvenile DermatomyositisSystemic Lupus ErythematosusCardiovascular DiseasePremature AtherosclerosisDermatologic ConditionsHealthy VolunteersNormal VolunteersCarcinoma, Merkel Cell
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Autoinflammatory Disease, Juvenile Dermatomyositis, Systemic Lupus Erythematosus, Cardiovascular Disease.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
How many clinical trials has National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), of which 3 are actively recruiting participants. These trials cover conditions including Autoinflammatory Disease, Juvenile Dermatomyositis, Systemic Lupus Erythematosus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) research focus on?
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) clinical trials span Autoinflammatory Disease, Juvenile Dermatomyositis, Systemic Lupus Erythematosus, Cardiovascular Disease, Premature Atherosclerosis, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) clinical trial?
To participate in a National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) trials with current recruitment status updated daily.
Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00059748
Recruiting
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Autoinflammatory Disease
NCT05440422 Phase 2
Recruiting
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Systemic Lupus Erythematosus
NCT02471352
Recruiting
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Dermatologic Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology